Literature DB >> 20443984

Amyotrophic lateral sclerosis: gender differences in the use of mechanical ventilation.

E Tollefsen1, B Midgren, P Bakke, O Fondenes.   

Abstract

BACKGROUND AND
PURPOSE: Invasive and non-invasive mechanical ventilation are therapeutic options in patients with amyotrophic lateral sclerosis (ALS). Related to known national ALS incidence figures, the study aims to examine gender aspects versus physiological data in patients with ALS commencing mechanical ventilation.
METHODS: ata from two nationwide registers involving all patients with ALS in Norway and Sweden who started invasive and non-invasive mechanical ventilation during 2002-2007.
RESULTS: The total ALS population on invasive and non-invasive mechanical ventilation comprised n = 308 subjects [Norway n = 96 (72% men), Sweden n = 212 (69% men)]. Compared to Swedish ALS incidence figures, our finding of a male/female ratio of 2.3/1 in patients with ALS on invasive and non-invasive mechanical ventilation shows a statistically significant male predominance in the use of mechanical ventilation (P-value 0.0084 Chi square). Only 6.7% of men and 3.8% of women had invasive (via tracheotomy) ventilation (P = 0.344). Initiation of mechanical ventilation was acute (not planned) in 18% of patients (no gender difference). Age distribution (mean age 62), pulmonary function tests (FVC%pred, FEV(1) %pred), daytime blood gas analyses (PaO(2), PaCO(2)) and survival revealed no statistically significant gender differences.
CONCLUSION: In Norwegian and Swedish patients with ALS on invasive and non-invasive mechanical ventilation, two-thirds were men. Associated with known national ALS male/female incidence figures, our finding shows that statistically significantly more men than women with ALS are using mechanical ventilation. Physiological data and survival were equal in both genders. This may indicate the need for a more aggressive approach to stimulate mechanical ventilation in female patients with ALS.
© 2010 The Author(s). Journal compilation © 2010 EFNS.

Entities:  

Mesh:

Year:  2010        PMID: 20443984     DOI: 10.1111/j.1468-1331.2010.03036.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis.

Authors:  Morten Magelssen; Trygve Holmøy; Morten Andreas Horn; Ove Arne Fondenæs; Knut Dybwik; Reidun Førde
Journal:  J Neurol       Date:  2018-09-14       Impact factor: 4.849

2.  Robot-assisted total gastrectomy for gastric cancer in a patient with amyotrophic lateral sclerosis receiving long-term tracheostomy invasive ventilation.

Authors:  Masaaki Nishi; Ryosuke Miyamoto; Kasane Shima; Hirokazu Miki; Hideo Terasawa; Chie Takasu; Kozo Yoshikawa; Takuro Oyama; Katsuya Tanaka; Yuishin Izumi; Mitsuo Shimada
Journal:  Int Cancer Conf J       Date:  2021-07-12

3.  Brain-computer interface (BCI) evaluation in people with amyotrophic lateral sclerosis.

Authors:  Lynn M McCane; Eric W Sellers; Dennis J McFarland; Joseph N Mak; C Steve Carmack; Debra Zeitlin; Jonathan R Wolpaw; Theresa M Vaughan
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-20       Impact factor: 4.092

4.  Contradictory Responses to the COVID-19 Pandemic in Amyotrophic Lateral Sclerosis Patients and Their Families and Caregivers in Japan.

Authors:  Masaru Yanagihashi; Tatsuki Sugisawa; Masaaki Fuchimoto; Yuuichi Saotome; Keiko Onozawa; Yukinori Matsumoto; Kota Bokuda; Junya Ebina; Mari Shibukawa; Takehisa Hirayama; Yoshitaka Murakami; Naohiro Washizawa; Satoru Ebihara; Osamu Kano
Journal:  Intern Med       Date:  2021-05-15       Impact factor: 1.271

Review 5.  Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectives.

Authors:  Giuseppe Fiorentino; Anna Annunziata; Anna Michela Gaeta; Maurizia Lanza; Antonio Esquinas
Journal:  Degener Neurol Neuromuscul Dis       Date:  2018-09-04

6.  Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.

Authors:  Charles Tzu-Chi Lee; Yi-Wen Chiu; Kai-Chen Wang; Chi-Shin Hwang; Kuan-Hsiang Lin; I-Ta Lee; Ching-Piao Tsai
Journal:  J Epidemiol       Date:  2012-10-27       Impact factor: 3.211

7.  Retrospective longitudinal study of ALS in Cyprus: Clinical characteristics, management and survival.

Authors:  Christiana A Demetriou; Petros M Hadjivasiliou; Kleopas A Kleopa; Yiolanda P Christou; Eleni Leonidou; Theodoros Kyriakides; Eleni Zamba-Papanicolaou
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

8.  Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.

Authors:  Matthew A White; Ziqiang Lin; Eugene Kim; Christopher M Henstridge; Emiliano Pena Altamira; Camille K Hunt; Ella Burchill; Isobel Callaghan; Andrea Loreto; Heledd Brown-Wright; Richard Mead; Camilla Simmons; Diana Cash; Michael P Coleman; Jemeen Sreedharan
Journal:  Acta Neuropathol Commun       Date:  2019-10-28       Impact factor: 7.801

9.  Factors associated with assisted ventilation use in amyotrophic lateral sclerosis: a nationwide population-based study in Korea.

Authors:  Seo Yeon Yoon; Han-Kyoul Kim; Mi Ji Kim; Jee Hyun Suh; Ja-Ho Leigh
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.